Gut microbiota induces immune-related alterations in gene expression, RNA methylation, and metabolism in glioblastoma revealed by single-cell and spatial multi-omics - Report - MDSpire
Advertisement
Gut microbiota induces immune-related alterations in gene expression, RNA methylation, and metabolism in glioblastoma revealed by single-cell and spatial multi-omics
Influence of Gut Microbiota on Immune-Related Gene Expression in Glioblastoma
Overview
This study investigates the impact of gut microbiota disruption on glioblastoma progression using a multi-omics approach. Key findings include altered gene expression and metabolomic changes linked to immune modulation and epigenetic regulation in glioma.
Background
Glioblastoma (GBM) is a highly aggressive brain tumor with poor prognosis and limited treatment options. Recent research indicates that gut microbiota may influence glioma progression through the gut-brain axis. Dysbiosis has been associated with various malignancies, including gliomas.
Data Highlights
No numerical data provided in the source material.
Key Findings
Antibiotic treatment led to reduced expression of Epha6 and increased expression of Tead1 in glioma.
Metabolomic profiling revealed decreased methionine levels in gliomas of antibiotic-treated mice.
Single-cell RNA sequencing showed an increased proportion of AC-like cells in the glioma microenvironment.
Disruption of intercellular communication and aberrations in EPHA and NRXN signaling pathways were observed.
The study identifies the EPHA pathway in the context of immune-mediated tumor progression.
Clinical Implications
Understanding the role of gut microbiota in glioblastoma may provide insights into therapeutic strategies.
Conclusion
This study enhances the understanding of the interplay between gut microbiota and glioblastoma.